Search Results - "Cruz Hernández, Juan Jesús"

Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts by Camps Herrero, Carlos, Antón Torres, Antonio, Cruz-Hernández, Juan Jesús, Carrato, Alfredo, Constenla, Manuel, Díaz-Rubio, Eduardo, Feyjoo Saus, Margarita, Garcia-Foncillas, Jesus, Gascón, Pere, Guillem, Vicente

“…There is a lack of standards for the diagnosis, assessment and management of breakthrough cancer pain (BTcP). La Fundación ECO (the Foundation for Excellence…”
Get full text

Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression by Blanco-Gómez, Adrián, Hontecillas-Prieto, Lourdes, Corchado-Cobos, Roberto, García-Sancha, Natalia, Salvador, Nélida, Castellanos-Martín, Andrés, Sáez-Freire, María Del Mar, Mendiburu-Eliçabe, Marina, Alonso-López, Diego, De Las Rivas, Javier, Lorente, Mar, García-Casas, Ana, Del Carmen, Sofía, Abad-Hernández, María Del Mar, Cruz-Hernández, Juan Jesús, Rodríguez-Sánchez, César Augusto, Claros-Ampuero, Juncal, García-Cenador, Begoña, García-Criado, Javier, Orimo, Akira, Gridley, Thomas, Pérez-Losada, Jesús, Castillo-Lluva, Sonia

“…SNAI2 overexpression appears to be associated with poor prognosis in breast cancer, yet it remains unclear in which breast cancer subtypes this occurs. Here we…”
Get full text

Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial by Fernández-Mateos, Javier, Pérez-García, Jéssica, Seijas-Tamayo, Raquel, Mesía, Ricard, Rubió-Casadevall, Jordi, García-Girón, Carlos, Iglesias, Lara, Carral Maseda, Alberto, Adansa Klain, Juan Carlos, Taberna, Miren, Vazquez, Silvia, Gómez, María Asunción, del Barco, Edel, Ocana, Alberto, González-Sarmiento, Rogelio, Cruz-Hernández, Juan Jesús

“…234 diagnostic formalin-fixed paraffin-embedded (FFPE) blocks from homogeneously treated patients with locally advanced head and neck squamous cell carcinoma…”
Get full text

Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma by Fernández-Mateos, Javier, Seijas-Tamayo, Raquel, Klain, Juan Carlos Adansa, Borgoñón, Miguel Pastor, Pérez-Ruiz, Elisabeth, Mesía, Ricard, del Barco, Elvira, Coloma, Carmen Salvador, Dominguez, Antonio Rueda, Daroqui, Javier Caballero, Fernández Ruiz, Encarnación, Cruz-Hernández, Juan Jesús, González-Sarmiento, Rogelio

“…Head and neck squamous cell carcinoma (HNSCC) is the sixth cancer on incidence worldwide. Tobacco and alcohol consumption are the most classical risk factors…”
Get full text

Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis by Olivares-Hernández, Alejandro, Del Barco Morillo, Edel, Parra Pérez, Carmen, Miramontes-González, José Pablo, Figuero-Pérez, Luis, Martín-Gómez, Teresa, Escala-Cornejo, Roberto, Bellido Hernández, Lorena, González Sarmiento, Rogelio, Cruz-Hernández, Juan Jesús, Ludeña de la Cruz, María Dolores

“…Mutations in the mismatch repair (MMR) system predict the response to immune checkpoint inhibitors (ICIs) like colon or gastric cancer. However, the MMR…”
Get full text

Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population by Fernández-Mateos, Javier, Seijas-Tamayo, Raquel, Adansa Klain, Juan Carlos, Pastor Borgoñón, Miguel, Pérez-Ruiz, Elisabeth, Mesía, Ricard, Del Barco, Elvira, Salvador Coloma, Carmen, Rueda Dominguez, Antonio, Caballero Daroqui, Javier, Fernández Ruiz, Encarnación, Ocana, Alberto, González-Sarmiento, Rogelio, Cruz-Hernández, Juan Jesús

“…Despite classical environmental risk factors like tobacco, alcohol or viral infection, not all individuals develop head and neck cancer. Therefore,…”
Get full text

Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers by Zugazagoitia, Jon, Pérez-Segura, Pedro, Manzano, Arancha, Blanco, Ignacio, Vega, Ana, Custodio, Ana, Teulé, Alex, Fachal, Laura, Martínez, Beatriz, González-Sarmiento, Rogelio, Cruz-Hernández, Juan Jesús, Chirivella, Isabel, Garcés, Vicente, Garre, Pilar, Romero, Atocha, Caldés, Trinidad, Díaz-Rubio, Eduardo, de la Hoya, Miguel

“…Early-onset diagnosis is an eligibility criterion for BRCA1 and BRCA2 ( BRCA ) testing in sporadic breast cancer patients. Limited family structure has been…”
Get full text

The Influence of Diet and Probiotics on the Response of Solid Tumours to Immunotherapy: Present and Future Perspectives by Olivares-Hernández, Alejandro, Figuero-Pérez, Luis, González-Sarmiento, Rogelio, León-Jiménez, David, Cruz-Hernández, Juan Jesús, Miramontes-González, José Pablo

“…Currently, various immunotherapeutic treatments are revolutionizing therapies that treat solid neoplasms. For these treatments, within immunotherapy, immune…”
Get full text

Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach by Castellanos-Martín, Andrés, Castillo-Lluva, Sonia, Sáez-Freire, María Del Mar, Blanco-Gómez, Adrián, Hontecillas-Prieto, Lourdes, Patino-Alonso, Carmen, Galindo-Villardon, Purificación, Pérez Del Villar, Luis, Martín-Seisdedos, Carmen, Isidoro-Garcia, María, Abad-Hernández, María Del Mar, Cruz-Hernández, Juan Jesús, Rodríguez-Sánchez, César Augusto, González-Sarmiento, Rogelio, Alonso-López, Diego, De Las Rivas, Javier, García-Cenador, Begoña, García-Criado, Javier, Lee, Do Yup, Bowen, Benjamin, Reindl, Wolfgang, Northen, Trent, Mao, Jian-Hua, Pérez-Losada, Jesús

“…An essential question in cancer is why individuals with the same disease have different clinical outcomes. Progress toward a more personalized medicine in…”
Get full text

Multimodal physical exercise and functional rehabilitation program in oncological patients with asthenia. study protocol by Fernández-Rodríguez, Eduardo José, González-Sánchez, Jesús, Puente-González, Ana Silvia, Recio-Rodríguez, José Ignacio, Sánchez-Gómez, Celia, Méndez-Sánchez, Roberto, Cruz-Hernández, Juan Jesús, Rihuete-Galve, María Isabel

“…Abstract Background The increase in the survival of oncology patients include multiple side effects as cancer-related asthenia and dyspnea, which represents a…”
Get full text

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence by Mendiburu‐Eliçabe, Marina, García‐Sancha, Natalia, Corchado‐Cobos, Roberto, Martínez‐López, Angélica, Chang, Hang, Hua Mao, Jian, Blanco‐Gómez, Adrián, García‐Casas, Ana, Castellanos‐Martín, Andrés, Salvador, Nélida, Jiménez‐Navas, Alejandro, Pérez‐Baena, Manuel Jesús, Sánchez‐Martín, Manuel Adolfo, Abad‐Hernández, María Del Mar, Carmen, Sofía Del, Claros‐Ampuero, Juncal, Cruz‐Hernández, Juan Jesús, Rodríguez‐Sánchez, César Augusto, García‐Cenador, María Begoña, García‐Criado, Francisco Javier, Vicente, Rodrigo Santamaría, Castillo‐Lluva, Sonia, Pérez‐Losada, Jesús

“…Background Luminal A tumours generally have a favourable prognosis but possess the highest 10‐year recurrence risk among breast cancers. Additionally, a…”
Get full text

Specific autonomy recovery programme in a comprehensive rehabilitation on functionality and respiratory parameters in oncological patients with dyspnoea. Study protocol by Fernández-Rodríguez, Eduardo José, González-Sánchez, Jesús, Puente-González, Ana Silvia, Recio-Rodríguez, José Ignacio, Sánchez-Gómez, Celia, Méndez-Sánchez, Roberto, Cruz-Hernández, Juan Jesús, Rihuete-Galve, María Isabel

“…Abstract Background Survival in cancer patients has increased exponentially in recent years, with multiple side effects caused by treatments. Cancer-related…”
Get full text

Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy by Olivares-Hernández, Alejandro, Del Barco Morillo, Edel, Miramontes-González, José Pablo, Figuero-Pérez, Luis, Pérez-Belmonte, Luis, Martín-Vallejo, Javier, Martín-Gómez, Teresa, Escala-Cornejo, Roberto, Vidal-Tocino, Rosario, Hernández, Lorena Bellido, Sarmiento, Rogelio González, Ludeña de la Cruz, María Dolores, Cruz-Hernández, Juan Jesús, Pérez, Carmen Parra

“…Determining predictive biomarkers for immune checkpoint inhibitors (ICIs) is a current challenge in oncology. Previous studies on non-small cell lung cancer…”
Get full text

Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer by Hitt, Ricardo, Mesía, Ricard, Lozano, Alicia, Iglesias Docampo, Lara, Grau, Juan J., Taberna, Miren, Rubió-Casadevall, Jordi, Martínez-Trufero, Javier, Morillo, Edel del Barco, García Girón, Carlos, Vázquez Estévez, Sergio, Cirauqui, Beatriz, Cruz-Hernández, Juan Jesús

“…•Locally advanced squamous cell carcinoma of the head and neck has a poor prognosis.•Concurrent chemoradiotherapy is the standard of care treatment for locally…”
Get full text

Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study by del Barco Morillo, Elvira, Mesía, Ricard, Adansa Klain, Juan Carlos, Vázquez Fernández, Silvia, Martínez-Galán, Joaquina, Pastor Borgoñon, Miguel, González-Rivas, Cyntia, Caballero Daroqui, Javier, Berrocal, Alfonso, Martínez-Trufero, Javier, Vera, Ruth, Cruz-Hernández, Juan Jesús

“…Highlights • Panitumumab and paclitaxel resulted in almost 50% of confirmed response rate. • This combination reached a median overall survival of 9.9 months…”
Get full text

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib by Jiménez-Fonseca, Paula, Martín, Miguel Navarro, Carmona-Bayonas, Alberto, Calvo, Alfonso, Fernández-Mateos, Javier, Redrado, Miriam, Capdevila, Jaume, Lago, Nieves Martínez, Lacasta, Adelaida, Muñarriz, Javier, Segura, Ángel, Fuster, Josep, Barón, Francisco, Llanos, Marta, Serrano, Raquel, Castillo, Alfredo, Cruz Hernández, Juan Jesús, Grande, Enrique

“…Several circulating biomarkers and single nucleotide polymorphisms (SNPs) have been correlated with efficacy and tolerability to antiangiogenic agents. These…”
Get full text

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk by Gómez-Vecino, Aurora, Corchado-Cobos, Roberto, Blanco-Gómez, Adrián, García-Sancha, Natalia, Castillo-Lluva, Sonia, Martín-García, Ana, Mendiburu-Eliçabe, Marina, Prieto, Carlos, Ruiz-Pinto, Sara, Pita, Guillermo, Velasco-Ruiz, Alejandro, Patino-Alonso, Carmen, Galindo-Villardón, Purificación, Vera-Pedrosa, María Linarejos, Jalife, José, Mao, Jian-Hua, Macías de Plasencia, Guillermo, Castellanos-Martín, Andrés, Sáez-Freire, María Del Mar, Fraile-Martín, Susana, Rodrigues-Teixeira, Telmo, García-Macías, Carmen, Galvis-Jiménez, Julie Milena, García-Sánchez, Asunción, Isidoro-García, María, Fuentes, Manuel, García-Cenador, María Begoña, García-Criado, Francisco Javier, García-Hernández, Juan Luis, Hernández-García, María Ángeles, Cruz-Hernández, Juan Jesús, Rodríguez-Sánchez, César Augusto, García-Sancho, Alejandro Martín, Pérez-López, Estefanía, Pérez-Martínez, Antonio, Gutiérrez-Larraya, Federico, Cartón, Antonio J, García-Sáenz, José Ángel, Patiño-García, Ana, Martín, Miguel, Alonso-Gordoa, Teresa, Vulsteke, Christof, Croes, Lieselot, Hatse, Sigrid, Van Brussel, Thomas, Lambrechts, Diether, Wildiers, Hans, Chang, Hang, Holgado-Madruga, Marina, González-Neira, Anna, Sánchez, Pedro L, Pérez Losada, Jesús

“…Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex trait with a…”
Get full text

Familial clustering of nasopharyngeal carcinoma in non-endemic area. Report of three families by Paredes-Durán, Leydy Mallerling, Del Barco-Morillo, Elvira, Baldeón-Conde, María Jesús, Medina-Valdivieso, Soledad, Guillen-Sacoto, María Cecilia, Cruz-Hernández, Juan Jesús

“…Nasopharyngeal carcinoma is the predominant tumour type arising in the nasopharynx. Its aetiology is multifactorial; racial and geographical distribution, EBV…”
Get more information

Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers by Fernández-Lázaro, Diego, García Hernández, Juan Luis, García, Alberto Caballero, Córdova Martínez, Alfredo, Mielgo-Ayuso, Juan, Cruz-Hernández, Juan Jesús

“…In recent years, there has been an increase in knowledge of cancer, accompanied by a technological development that gives rise to medical oncology. An…”
Get full text

Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer by Rodríguez Martín, Blanca, Fernández Rodríguez, Eduardo José, Rihuete Galve, María Isabel, Cruz Hernández, Juan Jesús

“…Oncology patients experience a large number of symptoms and, those referring to cognitive performance has an ever-increasing importance in clinical practice,…”
Get full text